Showing results (151-160 of 28,224) with videos related to

Sort By:
Pageof 2,823
BMC Cancer|March 23, 2019
Comparative sequence analysis of patient-matched primary colorectal cancer, metastatic, and recurrent metastatic tumors after adjuvant FOLFOX chemotherapyKazuaki Harada, Wataru Okamoto, Sachiyo Mimaki, et al.
Journal of Medical Primatology|July 24, 2004
Changes in hematology, biochemical values, and restraint ECG of rhesus monkeys (Macaca mulatta) following 6-month laboratory acclimationMasatoshi Hassimoto, Tsuyoshi Harada, Takuma Harada
Reproductive Medicine and Biology|July 13, 2022
Increased risk of obstetric complications in patients with adenomyosis: A narrative literature reviewTakashi Harada, Fuminori Taniguchi, Tasuku Harada
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 29, 2009
[Molecular mechanisms in myeloproliferative diseases and myelodysplastic syndromes]Hironori Harada, Yuka Harada, Akiro Kimura
Journal of Theoretical Biology|December 22, 1999
Short- vs. long-range disperser: the evolutionarily stable allocation in a lattice-structured habitatHarada
Current Diabetes Reviews|January 29, 2008
Role of cytokines and trophic factors in the pathogenesis of diabetic retinopathyYoshinori Mitamura, Chikako Harada, Takayuki Harada
Progress in Retinal and Eye Research|December 27, 2005
The role of cytokines and trophic factors in epiretinal membranes: involvement of signal transduction in glial cellsChikako Harada, Yoshinori Mitamura, Takayuki Harada
Leukemia|March 31, 2022
Myeloid neoplasms and clonal hematopoiesis from the RUNX1 perspectiveYoshihiro Hayashi, Yuka Harada, Hironori Harada
Annals of Nuclear Medicine|March 27, 2019
Preliminary clinical assessment of dynamic 18F-fluorodeoxyglucose positron emission tomography/computed tomography for evaluating lymph node metastasis in patients with lung cancer: a prospective studyTakayoshi Shinya, Yoichi Otomi, Michiko Kubo, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
BAYONET trial: staged combination with encorafenib, binimetinib, plus cetuximab following encorafenib plus cetuximab for BRAF V600E-mutant metastatic colorectal cancerY Matsubara, H Bando, D Kotani, et al.
Pageof 2,823